Author

Keith Kyewalabye

Observed name: K Kyewalabye

Institution: SUNY Upstate Medical University

Observed institutions: The University of Texas MD Anderson Cancer Center, University of California, San Francisco, SUNY Upstate Medical University

ORCID: 0000-0003-3645-6328

Observed ORCID: 0000-0003-3645-6328

OpenAlex ID: A5066366100

Enhancing CAR-T cell metabolism to overcome hypoxic conditions in the brain tumor microenvironment

2024 · Ryusuke Hatae, Keith Kyewalabye, et al. · JCI Insight · 65

Ataxia-Telangiectasia Mutated Loss-of-Function Displays Variant and Tissue-Specific Differences across Tumor Types

2024 · Patrick G. Pilié, Virginia Giuliani, et al. · Clinical Cancer Research · 21

Comparative evaluation of CAR-expressing T-, NK-, NKT-cells, and macrophages in an immunocompetent mouse glioma model

2025 · Ryusuke Hatae, Payal B Watchmaker, et al. · Neuro-Oncology Advances · 14

Abstract 6104: Comparative evaluation of CAR-expressing T-, NK-, NKT-cells and macrophages in an immunocompetent mouse glioma model

2025 · Payal B. Watchmaker, Ryusuke Hatae, et al. · Cancer Research · 1

Identifying functional loss of ATM gene in patients with advanced cancer.

2020 · Patrick Glen Pilie, Jinesh S. Gheeya, et al. · Journal of Clinical Oncology · 1

AI-powered prognostic index predicts immunotherapy response in NSCLC using PD-L1 and clinical data

2026 · Tamara Jamaspishvili, Keith Kyewalabye, et al. · Journal of Pathology Informatics

P08.07.a Comprehensive Evaluation of Car-engineered Immune Cell Subsets Reveals Therapeutic Synergy in an Immune-competent Glioblastoma Model

2025 · R Hatae, P Watchmaker, et al. · Neuro-Oncology

Data from Ataxia-Telangiectasia Mutated Loss-of-Function Displays Variant and Tissue-Specific Differences across Tumor Types

2024 · Patrick G. Pilié, Virginia Giuliani, et al.

Supplementary Table S1 from Ataxia-Telangiectasia Mutated Loss-of-Function Displays Variant and Tissue-Specific Differences across Tumor Types

2024 · Patrick G. Pilié, Virginia Giuliani, et al.

Supplementary S1-S8 from Ataxia-Telangiectasia Mutated Loss-of-Function Displays Variant and Tissue-Specific Differences across Tumor Types

2024 · Patrick G. Pilié, Virginia Giuliani, et al.

Exth-18. Development of a Transgenic Mouse Model Enabling Comparative Analysis of Chimeric Antigen Receptor (car)-expressing Immune Cell Populations for Cancer Immunotherapy

2023 · Ryusuke Hatae, Payal Watchmaker, et al. · Neuro-Oncology

Abstract 1774: Pre-treatment of CAR-T cells with met+rap improves the mitochondrial function and anti-tumor efficacy in a hypoxic glioma microenvironment

2023 · Ryusuke Hatae, Keith Kyewalabye, et al. · Cancer Research

Abstract 3432: Ataxia-telangiectasia mutated loss of function displays variant and tissue specific differences across tumor types

2023 · Patrick G. Pilie, Daniel Mcgrail, et al. · Cancer Research

Exth-06. Pre-infusion Metabolic Modulation of Car-t Cells Promotes the Resistance to the Suppressive Effects of Hypoxia and Enhances Anti-tumor Effects Against Intracerebral Gliomas

2022 · Ryusuke Hatae, Keith Kyewalabye, et al. · Neuro-Oncology

Works count: 14

Citation count: 102

H-index: 3

I10-index: 3